"We may earn commission via affiliate links within this post via affiliate links to products or services associated with content in this article. Barry uses the commission to aid people needing assistance"
The original 20-year patent was purchased in 1999. I originally published this article in 2012 to help the cause. Since then not a whole lot changed. But this patent is getting a lot of attention because in the last few months The Drug Enforcement Agency (DEA) voted on August 11 2016. The vote was very clear that marijuana would stay schedule 1 because it “has no medical use”.
This of course was shocking. As our original article shows they know the opposite has been true since 1999 (probably earlier than this). This patent, from the '90s clearly says Marijuana has “some medicinal benefits.”
This is another recent example of a greater problem of the use of patents as a block to innovation.
Thankfully it is clear that word is getting out. The Denver Post has a huge article talking and showing just how much attention this is getting. We are still in full support of building awareness. This is such an obvious example of failed drug system.
What you may not yet have heard is that the patent expires in just 2 more years. Myles of New York-based Kannalife Sciences Inc. said “The patent expires on April 21, 2019, after which anyone would be free to develop drugs based on these cannabinoids that, like all drugs, would require FDA approval to demonstrate safety and effectiveness in humans.”
Great so eventually people in the USA might get back to research, (this is only one of many blocks). My only thought is what will happen when the patent runs out? Will it make much difference at all? Lately, it is clear that Israel is producing top-notch research. As a result, many of the world's best are going there. To the history buffs, this is no surprise since CBD than THC was isolated by Prof. Raphael Mechoulam and his team of scientists in the early 1960’s.
There is always a new front to the battle. Most recently I have gone headfirst into Trip to Wellness. The life-changing powers of plant medicine. Ibogaine, Ayahuasca, and many other amazing plant medicines are not being used to help the millions in need. Mostly because there is less profit in it.
If you are interested in helping promote the newest cause visit us over at the Trip to Wellness page. Or just send us a message here and let us know you want to help.
An original article from 2012: DEA Owns US Patent 6630507 for Medical Marijuana
The U.S. government classifies marijuana as a Schedule 1 drug, defined as having "no medicinal value and highly addictive." Yet, they own US patent 6630507 for using cannabinoids as an antioxidant and neuro-protectant.
Yes, you are reading this correctly: The U.S. government, which includes the DEA, has patented medical marijuana.
The patent begins:
“Cannabinoids have been found to have antioxidant properties, unrelated to NDMA receptor antagonism. This new found property makes cannabinoids useful in treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants…”
Millions of Americans have been caged for marijuana while their torturers hold a patent for the illegal plant. Most justifiably agree the hypocrisy is darkly hysterical.
Watch the video below to learn more about the government's secret patent on cannabis.
Truth in Media: Feds own patent on cannabis as medicine
A message from NeverGetBusted
NeverGetBusted is a humanitarian cause. We are famous for freeing prisoners and defendants. If you have been arrested for a drug crime or have a loved one in prison, schedule a consultation with Barry by clicking the ALERT BARRY button below. NeverGetBusted has a special alert system set for your submission so we will respond within a few hours. No case is too big or too small. Barry will examine any drug case for mistakes.